VHL mutations are associated with increased expression of VHL and ubiquitin in clear cell renal cell carcinoma.

被引：0
|
作者：
Hughson, M [1 ]
He, Z [1 ]
Liu, S [1 ]
Shingleton, WB [1 ]
机构：
[1] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA
来源：
MODERN PATHOLOGY | 2001年 / 14卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
641
引用
收藏
页码：111A / 111A
页数：1
相关论文
共 50 条
  • [1] VHL mutations are associated with increased expression of VHL and ubiquitin in clear cell renal cell carcinoma.
    Hughson, M
    He, Z
    Liu, S
    Shingleton, WB
    LABORATORY INVESTIGATION, 2001, 81 (01) : 111A - 111A
  • [2] Determination of the consequences of VHL mutations on VHL transcripts in renal cell carcinoma
    Taylor, Claire
    Craven, Rachel A.
    Harnden, Patricia
    Selby, Peter J.
    Banks, Rosamonde E.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 41 (04) : 1229 - 1240
  • [3] Homologous repair deficiency in VHL-mutated clear cell renal cell carcinoma.
    Pilie, Patrick Glen
    Zhou, Lijun
    Peterson, Christine B.
    Peng, Yang
    Peng, Guang
    Jonasch, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [4] Specific Localization of Missense Mutations in the VHL Gene in Clear Cell Renal Cell Carcinoma
    Mikhailenko, D. S.
    Zhinzhilo, T. A.
    Kolpakov, A. V.
    Kekeeva, T. V.
    Strel'nikov, V. V.
    Nemtsova, M. V.
    Kushlinskii, N. E.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2017, 163 (04) : 465 - 468
  • [5] Specific Localization of Missense Mutations in the VHL Gene in Clear Cell Renal Cell Carcinoma
    D. S. Mikhailenko
    T. A. Zhinzhilo
    A. V. Kolpakov
    T. V. Kekeeva
    V. V. Strel’nikov
    M. V. Nemtsova
    N. E. Kushlinskii
    Bulletin of Experimental Biology and Medicine, 2017, 163 : 465 - 468
  • [6] A phase II study of talazoparib and avelumab in VHL deficient clear cell renal cell carcinoma.
    Kotecha, Ritesh
    Lee, Chung-Han
    McHugh, Deaglan Joseph
    Dadoun, Chloe
    Knezevic, Andrea
    Carlo, Maria Isabel
    Feld, Emily
    Shapnik, Natalie
    Shah, Neil J.
    Feldman, Darren R.
    Motzer, Robert J.
    Voss, Martin H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [7] VHL inactivation in sporadic clear cell renal carcinoma
    Mikhaylenko, D. S.
    Kurynin, R. V.
    Popov, A. M.
    Karyakin, O. B.
    Enikeev, M. E.
    Alyaev, Yu. G.
    Nemtsova, M. V.
    Zaletayev, D. V.
    MOLECULAR BIOLOGY, 2008, 42 (01) : 64 - 69
  • [8] The VHL/HIF axis in clear cell renal carcinoma
    Shen, Chuan
    Kaelin, William G., Jr.
    SEMINARS IN CANCER BIOLOGY, 2013, 23 (01) : 18 - 25
  • [9] VHL inactivation in sporadic clear cell renal carcinoma
    D. S. Mikhaylenko
    R. V. Kurynin
    A. M. Popov
    O. B. Karyakin
    M. E. Enikeev
    Yu. G. Alyaev
    M. V. Nemtsova
    D. V. Zaletayev
    Molecular Biology, 2008, 42 : 64 - 69
  • [10] A polymophism in the promoter of the VHL gene which is associated with clear cell renal cell carcinoma
    Page, T
    Ollerrenshaw, M
    Hammonds, JC
    Demaine, AG
    JOURNAL OF UROLOGY, 2005, 173 (04): : 171 - 171
12345